Tatva Chintan Pharma Chem makes bumper debut with 95% premium on the BSE

29 Jul 2021 Evaluate

Tatva Chintan Pharma Chem has debuted at Rs 2,111.80 on the BSE, up by 1028.80 points or 95.00% from its issue price of Rs 1083.

The scrip is currently trading at Rs 2308.00, up by 1225 points or 113.11% from its issue price. It has touched a high and low of Rs 2486.30 and Rs 2111.80 respectively. So far 6.16 lakh shares were traded on the counter.

The offering which was opened for subscription between July 16, 2021 and July 20, 2021, was oversubscribed 180 times. The massive IPO consisted of a fresh issue of Rs 225 crore and an Offer for Sale (OFS) worth Rs 275 crore by its shareholders. The issue price was fixed at Rs 1083 per share i.e. at upper end of price band of Rs 1073- 1083 apiece.

Tatva Chintan Pharma Chem is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals.

Tatva Chintan Pharma Share Price

1387.00 -31.50 (-2.22%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×